Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Revvity
< Previous
1
2
Next >
Revvity Collaborates with MDIC and NIST to Launch New Somatic Cancer Reference Standards to Monitor Diagnostic Assay Accuracy
November 10, 2025
From
Revvity
Via
Business Wire
Revvity to Acquire ACD/Labs to Expand its Signals Software Capabilities
November 10, 2025
From
Revvity
Via
Business Wire
Tickers
RVTY
Revvity to Present at Upcoming Investor Conferences
October 28, 2025
From
Revvity
Via
Business Wire
Tickers
RVTY
Revvity Announces Financial Results for the Third Quarter of 2025
October 27, 2025
From
Revvity
Via
Business Wire
Tickers
RVTY
Revvity Board Declares Quarterly Dividend
October 23, 2025
From
Revvity
Via
Business Wire
Tickers
RVTY
Revvity Showcases Progress with Purpose in 2025 Impact Report
October 14, 2025
From
Revvity
Via
Business Wire
Tickers
RVTY
Revvity to Hold Earnings Call on Monday, October 27, 2025
October 06, 2025
From
Revvity
Via
Business Wire
Tickers
RVTY
Revvity Announces Program to Revolutionize the Early Detection of Type 1 Diabetes
October 02, 2025
From
Revvity
Via
Business Wire
Tickers
RVTY
Revvity Unveils New AI Software Offering to Transform Preclinical Imaging Analysis
September 29, 2025
From
Revvity
Via
Business Wire
Tickers
RVTY
Revvity and Profluent Collaborate to Launch AI-Enhanced Adenine Deaminase Pin-point Base Editing Systems
September 22, 2025
From
Revvity
Via
Business Wire
Tickers
RVTY
Revvity Establishes In Vivo Imaging Center of Excellence in North Carolina
September 02, 2025
From
Revvity
Via
Business Wire
Tickers
RVTY
Revvity to Present at Upcoming Investor Conferences
August 18, 2025
From
Revvity
Via
Business Wire
Tickers
RVTY
Revvity Launches Innovative Reagent Technology to Accelerate Development of Next-Generation Targeted Therapeutics
August 06, 2025
From
Revvity
Via
Business Wire
Tickers
RVTY
Revvity Announces Financial Results for the Second Quarter of 2025
July 28, 2025
From
Revvity
Via
Business Wire
Tickers
RVTY
Revvity Board Declares Quarterly Dividend
July 24, 2025
From
Revvity
Via
Business Wire
Tickers
RVTY
Revvity to Hold Earnings Call on Monday, July 28, 2025
July 07, 2025
From
Revvity
Via
Business Wire
Tickers
RVTY
Revvity Introduces New IVD Reference Standards for Monitoring Oncology Diagnostic Testing Workflows
June 02, 2025
From
Revvity
Via
Business Wire
Tickers
RVTY
Revvity’s EUROIMMUN Unveils New Fully Automated Instrument for Specialty Testing
May 19, 2025
From
Revvity
Via
Business Wire
Tickers
RVTY
Revvity to Present at Upcoming Investor Conferences
April 30, 2025
From
Revvity
Via
Business Wire
Tickers
RVTY
Revvity Announces Financial Results for the First Quarter of 2025
April 28, 2025
From
Revvity
Via
Business Wire
Tickers
RVTY
Revvity Board Declares Quarterly Dividend
April 24, 2025
From
Revvity
Via
Business Wire
Tickers
RVTY
Revvity Fuels the Future of Cancer Science with New Research Solutions
April 22, 2025
From
Revvity
Via
Business Wire
Revvity to Hold Earnings Call on Monday, April 28, 2025
April 03, 2025
From
Revvity
Via
Business Wire
Tickers
RVTY
Revvity Secures FDA Approval for Improved Automated Latent Tuberculosis Test
April 02, 2025
From
Revvity
Via
Business Wire
Tickers
RVTY
Revvity Signals Software Unveils Unified Data Platform to Accelerate Drug Discovery
April 02, 2025
From
Revvity
Via
Business Wire
Revvity Expands Alliance with Genomics England to Drive Research into Newborn Genomic Sequencing in England
March 20, 2025
From
Revvity
Via
Business Wire
Tickers
RVTY
Revvity’s EUROIMMUN Receives CE Mark for Novel Measles Antibody Detection Assay
March 03, 2025
From
Revvity
Via
Business Wire
Tickers
RVTY
Revvity Wins Permanent Injunction Enforcing Agreements with Cloud Software Group
February 20, 2025
From
Revvity
Via
Business Wire
Tickers
RVTY
Revvity to Present at Upcoming Investor Conferences
February 20, 2025
From
Revvity
Via
Business Wire
Tickers
RVTY
Revvity Announces Financial Results for the Fourth Quarter and Full Year of 2024
January 31, 2025
From
Revvity
Via
Business Wire
Tickers
RVTY
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today